Middle Aged

Dennis, J. M., Young, K. G., McGovern, A. P., Mateen, B. A., Vollmer, S. J., Simpson, M. D., et al. (2022). Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study. Lancet Digit Health, 4, e873-e883. http://doi.org/10.1016/s2589-7500(22)00174-1
View
Rapsomaniki, E., Shah, A., Perel, P., Denaxas, S., George, J., Nicholas, O., et al. (2014). Prognostic models for stable coronary artery disease based on electronic health record cohort of 102 023 patients. Eur Heart J, 35, 844-52. http://doi.org/10.1093/eurheartj/eht533
View
Armstrong, D., Dregan, A., Ashworth, M., & White, P. (2022). Prior antibiotics and risk of subsequent Herpes zoster: A population-based case control study. Plos One, 17, e0276807. http://doi.org/10.1371/journal.pone.0276807
View
Conrad, N., Verbeke, G., Molenberghs, G., Goetschalckx, L., Callender, T., Cambridge, G., et al. (2022). Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. Lancet, 400, 733-743. http://doi.org/10.1016/s0140-6736(22)01349-6
View
Birkeland, K. I., Bodegard, J., Banerjee, A., Kim, D. J., Norhammar, A., Eriksson, J. W., et al. (2021). Lower cardiorenal risk with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study. Diabetes Obes Metab, 23, 75-85. http://doi.org/10.1111/dom.14189
View
Sansbury, L. B., Rothnie, K. J., Bains, C., Compton, C., Anley, G., & Ismaila, A. S. (2021). Healthcare, Medication Utilization and Outcomes of Patients with COPD by GOLD Classification in England. Int J Chron Obstruct Pulmon Dis, 16, 2591-2604. http://doi.org/10.2147/copd.s318969
View
Stafford, M., Knight, H., Hughes, J., Alarilla, A., Mondor, L., Kone, P., et al. (2022). Associations between multiple long-term conditions and mortality in diverse ethnic groups. Plos One, 17, e0266418. http://doi.org/10.1371/journal.pone.0266418
View
Suissa, S., Dell'Aniello, S., & Ernst, P. (2022). Fluticasone-Based versus Budesonide-Based Triple Therapies in COPD: Real-World Comparative Effectiveness and Safety. Copd, 19, 109-117. http://doi.org/10.1080/15412555.2022.2035705
View
Suissa, S., Dell'Aniello, S., & Ernst, P. (2022). Discontinuation of Inhaled Corticosteroids from Triple Therapy in COPD: Effects on Major Outcomes in Real World Clinical Practice. Copd, 19, 133-141. http://doi.org/10.1080/15412555.2022.2045265
View
Li, X., Raventós, B., Roel, E., Pistillo, A., Martinez-Hernandez, E., Delmestri, A., et al. (2022). Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis. Bmj, 376, e068373. http://doi.org/10.1136/bmj-2021-068373
View